A Randomized Controlled Trial of Prophylactic Rituximab to Reduce Clinically Significant EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation
NA
This is a single-center, prospective, randomized, open-label clinical trial...
Status
Not Yet Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease
PHASE1
OBJECTIVES: I. Evaluate the safety, tolerance, and potential efficacy of 3 ...
Immunoglobiulin-specific Prophylaxis of Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
N/A
Human cytomegalovirus (CMV) is a globally prevalent, human-specific herpesv...